drugset / Trial / NCT00963599
Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117)
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will evaluate the ability of oral montelukast/loratadine to improve the signs and symptoms of seasonal allergic rhinitis compared with loratadine alone, montelukast alone and placebo.
Timeline
- Start
- 1999-09
- Primary completion
- 1999-11
- Completion
- 1999-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Loratadine | Small molecule | 10 mg | Oral |
| Subject | Montelukast | Other / unclassified | 10 mg | Oral |